AgeX Therapeutics, Inc.

AMEX:AGE

0.4302 (USD) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -14.803-10.522-8.582-10.976-12.384-7.731-6.637
Depreciation & Amortization 0.1310.1320.1311.6820.9510.5350.682
Deferred Income Tax -1.0970-0.6330.119-0.278-3.283-1.875
Stock Based Compensation 0.6480.760.9990.9091.9071.4730.752
Change In Working Capital 0.6250.329-0.884-0.062-0.410.2110.776
Accounts Receivables -0.6070.0210.1280.01-0.232-0.0240
Inventory -1.150-0.128-0.010.232-0.4210
Accounts Payables 1.150.144-0.7720.340.1690.6480.267
Other Working Capital 1.2320.164-0.112-0.402-0.5790.0080.509
Other Non Cash Items 6.6963.3621.1140.4870.0540.80.017
Operating Cash Flow -7.8-5.939-7.855-7.817-10.16-7.995-6.285
Investing Activities:
Investments In Property Plant And Equipment 000-0.02-0.641-1.893-0.001
Acquisitions Net 000.46600.3543.2150
Purchases Of Investments 0000-0.35400
Sales Maturities Of Investments 00000.35400
Other Investing Activites -1000.20-0.0740.0050.006
Investing Cash Flow -1000.666-0.02-0.3611.3270.005
Financing Activities:
Debt Repayment 17.5-6-7-0.015-0.03500
Common Stock Issued 00.0080.4960.0210.056010
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 011.99213.755.9556.24463.275
Financing Cash Flow 17.567.2465.9616.265613.275
Other Information:
Effect Of Forex Changes On Cash 0000.0010.00100.121
Net Change In Cash -0.30.0610.057-1.875-4.255-0.6687.116
Cash At End Of Period 0.3450.6950.6340.5772.4526.7077.375